Topic

clascoterone

Bar chart from a post hoc analysis in adolescents aged 12 to 17 with moderate-to-severe acne: at week 12, 51.5 percent of 123 using clindamycin, adapalene and benzoyl peroxide gel reached treatment success versus 24.9 percent of 50 using vehicle.

Teen acne: what the 2024 acne guideline recommends

Which acne treatments carry strong recommendations for adolescents in the 2024 American Academy of Dermatology guideline, what the trials behind them found, and where the evidence is thin.

Sep 12, 2026 · 8 min · Medically reviewed

MedicalDermatologyNews

Medical

Clascoterone for acne: topical antiandrogen evidence

Clascoterone is an FDA-approved topical androgen receptor inhibitor for acne. See the phase 3 results, limits, adverse effects, and unanswered comparisons.

Aug 1, 2026 · 5 min · Medically reviewed